Effects of Synbiotic Supplementation on Blood and Urinary Concentrations of Factors Related to Kidney Stone Formation in Overweight or Obese Patients with Hyperoxaluria: A Randomized Controlled Trial.
Urology journal./Urology jornal. · 29.05.2026 · 23 (1) · 7-11
DOI: 10.22037/uj.v22i.8740 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Urology journal./Urology jornal., erschienen am 29.05.2026. Verfasst von Niloofarsadat Maddahi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Islamic Republic of Iran. Hauptthemen laut MEDLINE: Kidney Calculi, Hyperoxaluria, Obesity, Overweight.
Abstract (Originalsprache)
PURPOSE: This study investigated the impact of synbiotics on blood and urinary concentrations of factors related to kidney stone formation in overweight or obese patients with hyperoxaluria. MATERIALS AND METHODS: A randomized double-blind clinical trial was conducted involving forty-four patients assigned to either synbiotic or placebo groups. Participants received their respective capsules twice daily for 12 weeks. Blood and 24-hour urine samples were collected at baseline and week 12 for biochemical analyses. RESULTS: Urinary oxalate significantly decreased in the synbiotic group compared with both baseline (P=.001) and placebo (P=.001). Other biochemical markers showed no significant differences, while urine volume increased in both groups without between-group variance. CONCLUSION: Synbiotic supplementation significantly reduced urinary oxalate but did not affect other blood or urinary parameters associated with kidney stone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Islamic Republic of Iran.
- Pediatric Gastroenterology, Hepatology & Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
- Department of Nutrition, School of Public Health, Research Center for Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Islamic Republic of Iran.
- Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Center of Excellence in Urology, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
- Department of Clinical Nutrition & Dietetics, National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic…
- Department of Urology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran.
Zitieren
APA
Maddahi, N., Zamani, B., Nadjarzadeh, A., Basiri, A., Tabibi, H., Kashefi, M., & Tabatabai, S. A. (2026). Effects of Synbiotic Supplementation on Blood and Urinary Concentrations of Factors Related to Kidney Stone Formation in Overweight or Obese Patients with Hyperoxaluria: A Randomized Controlled Trial. Urology journal./Urology jornal., 23(1), 7-11. https://doi.org/10.22037/uj.v22i.8740
Vancouver
Maddahi N, Zamani B, Nadjarzadeh A, Basiri A, Tabibi H, Kashefi M, et al. Effects of Synbiotic Supplementation on Blood and Urinary Concentrations of Factors Related to Kidney Stone Formation in Overweight or Obese Patients with Hyperoxaluria: A Randomized Controlled Trial. Urology journal./Urology jornal.. 2026;23(1):7-11. doi:10.22037/uj.v22i.8740
BibTeX
@article{Maddahi2026,
author = {Maddahi, Niloofarsadat and Zamani, Behzad and Nadjarzadeh, Azadeh and Basiri, Abbas and Tabibi, Hadi and Kashefi, Mehdi and Tabatabai, Sayyed Abbas},
title = {Effects of Synbiotic Supplementation on Blood and Urinary Concentrations of Factors Related to Kidney Stone Formation in Overweight or Obese Patients with Hyperoxaluria: A Randomized Controlled Trial},
journal = {Urology journal./Urology jornal.},
year = {2026},
volume = {23},
number = {1},
pages = {7--11},
doi = {10.22037/uj.v22i.8740}
}
EUVIMED